ConductScience.org, home

Paper39754146

Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.

Zhang J and 15 others. Chin Med, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway. Papers, record 39754146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39754146

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.
PubMed
Journal
Chin Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-02-10
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang JJingyuan
2Yang SSiyun
3Chen XXiaodong
4Zhang FFanqin
5Guo SSiyu
6Wu CChao
7Wang TTieshan
8Wang HHaojia
9Lu SShan
10Qiao CChuanqi
11Sheng XXiaoguang
12Liu SShuqi
13Zhang XXiaomeng
14Luo HHua
15Li QQinglin
16Wu JJiaruihttps://orcid.org/0000-0002-1617-6110

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82074284The National Natural Science Foundation of ChinaPubMed
ZYYCXTD-C-202005-10The China National Traditional Chinese Medicine Inheritance and Innovation Team Sub-ProjectPubMed
2020MZ298-110101The China Medical Association of Minorities Research ProjectPubMed
MDK2020013The Open Fund Project, Associated Key Laboratory of Traditional Mongolia Medicine Research and Development, National Ethnic Affairs Commission and Ministry of Education of ChinaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in39930460Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.https://conductscience.org/library/papers/39930460

Source PubMed

Download CSV of comments and corrections

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136633525Cancer statistics, 2023.CA Cancer J Clin2023https://conductscience.org/library/papers/36633525PubMed
235143424Cancer statistics in China and United States, 2022: profiles, trends, and determinants.Chin Med J (Engl)2022https://conductscience.org/library/papers/35143424PubMed
338468501[Cancer incidence and mortality in China, 2022].Zhonghua Zhong Liu Za Zhi2024https://conductscience.org/library/papers/38468501PubMed
434273294Lung cancer.Lancet2021https://conductscience.org/library/papers/34273294PubMed
527188576Non-small-cell lung cancer.Nat Rev Dis Primers2015https://conductscience.org/library/papers/27188576PubMed
631549028Nano-Bio Interactions of Extracellular Vesicles with Gold Nanoislands for Early Cancer Diagnosis.Research (Wash D C)2018https://conductscience.org/library/papers/31549028PubMed
731912037Tandem Molecular Self-Assembly Selectively Inhibits Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress.Research (Wash D C)2019https://conductscience.org/library/papers/31912037PubMed
87521815Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature.Chest1994https://conductscience.org/library/papers/7521815PubMed
911784875Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med2002https://conductscience.org/library/papers/11784875PubMed
1017473659
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.
J Thorac Oncol2007https://conductscience.org/library/papers/17473659PubMed
1115886310Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology.J Clin Oncol2005https://conductscience.org/library/papers/15886310PubMed
1211991792The importance of pharmacological synergy in psychoactive herbal medicines.Altern Med Rev2002https://conductscience.org/library/papers/11991792PubMed
1325535693Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.J Thorac Oncol2015https://conductscience.org/library/papers/25535693PubMed
1430374901Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails.Am J Clin Dermatol2018https://conductscience.org/library/papers/30374901PubMed
1518165622Review: side effects of approved molecular targeted therapies in solid cancers.Oncologist2007https://conductscience.org/library/papers/18165622PubMed
1631601994The great escape: tumour cell plasticity in resistance to targeted therapy.Nat Rev Drug Discov2020https://conductscience.org/library/papers/31601994PubMed
1738430032Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma.Cell Mol Biol (Noisy-le-grand)2024https://conductscience.org/library/papers/38430032PubMed
1826203858Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.Cell Death Dis2015https://conductscience.org/library/papers/26203858PubMed
1922037177Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.Adv Med Sci2011https://conductscience.org/library/papers/22037177PubMed
2034543169Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway.Pharm Biol2021https://conductscience.org/library/papers/34543169PubMed

See all 70 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41350419Efficacy and safety of AiDi injection in treating primary liver cancer: a systematic review on 70 randomized controlled trials.Sci Rep2025https://conductscience.org/library/papers/41350419PubMed
41041648Cantharidin: a double-edged sword in medicine and toxicology.Front Pharmacol2025https://conductscience.org/library/papers/41041648PubMed
40001110Traditional Chinese medicine in lung cancer treatment.Mol Cancer2025https://conductscience.org/library/papers/40001110PubMed
39930460Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.Chin Med2025https://conductscience.org/library/papers/39930460PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ITGB33690PubTator's text mininghttps://conductscience.org/library/genes/3690NCBI Gene
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
PTK25747PubTator's text mininghttps://conductscience.org/library/genes/5747NCBI Gene
TNC3371PubTator's text mininghttps://conductscience.org/library/genes/3371NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39754146

GET https://conductscience.org/api/papers/v1/39754146/references?page=2